Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasm Metastasis 1

Interventions

Cisplatin 9Radiotherapy 6Carboplatin 6toripalimab 5pembrolizumab 5Surgical Procedures, Operative 5Nivolumab 5Docetaxel 5Cetuximab 5Paclitaxel 4Drug Therapy 4Taxes 3trilaciclib 2tislelizumab 2nimotuzumab 2camrelizumab 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Magnetic Resonance Spectroscopy 2Injections 2Cyclophosphamide 2Blood Specimen Collection 2130-nm albumin-bound paclitaxel 2spartalizumab 1penpulimab 1fludarabine phosphate 1fludarabine 1dexamethasone-(C21-phosphoramide)-(anti-EGFR) 1dalpiciclib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Squamous Cell Carcinoma of Head and Neck × Combined Modality Therapy × Clear all
NCT07393477 2026-02-06

Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma

Sir Run Run Shaw Hospital

Phase 2 Not yet recruiting
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡